Full Episode
Friday, Nov 14
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

Help us continue to be your leading source for trustworthy news and information

Take our 2025 PBS NewsHour audience survey

Take the survey
Geoff Bennett and Amna Nawaz for PBS NewsHour
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

FDA

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live

Dec 13

After recalls and infections, experts say safer eyedrops will require new FDA powers

By Matthew Perrone, Associated Press

Unlike prescription drugs, eyedrops and other over-the-counter products don't get preliminary review by the Food and Drug Administration.

Continue reading

Dec 09

Watch 5:08
Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’

By John Yang, Claire Mufson, Harry Zahn

Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale…

Continue watching

Dec 06

FDA inspects maker of lead-tainted applesauce pouches in Ecuador

By JoNel Aleccia, Associated Press

The FDA said this week that at least 64 young children from 27 states have reported illnesses potentially linked to the products, which were recalled in late October.

Continue reading

Nov 16

Indian manufacturer recalls eyedrops previously cited in FDA warning

By Matthew Perrone, Associated Press

The action is mainly a formality, since the FDA had already alerted U.S. stores last month to stop selling the over-the-counter drops.

Continue reading

Nov 08

FDA approves new version of diabetes drug Mounjaro to be sold for weight loss

By JoNel Aleccia, Associated Press

The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds. It is the latest diabetes drug approved for weight loss, joining Novo Nordisk's Wegovy, a high-dose version of Ozempic.

Continue reading

Oct 31

WATCH: Sickle cell gene therapy gets review from FDA advisory committee

By Laura Ungar, Associated Press

If approved, it would be the first gene therapy on the U.S. market based on CRISPR, the gene editing tool that won its inventors the Nobel Prize in 2020.

Continue reading

Oct 30

Eyedrops from CVS, Rite Aid and others carry possible infection risk, FDA says

By Associated Press

The agency says consumers should stop using the products immediately and avoid purchasing any found in pharmacies and other stores.

Continue reading

Oct 28

Watch 6:02
Investigation finds Philips hid safety issues with its CPAP machines for years

By Ali Rogin, Andrew Corkery

CPAP machines help about 8 million Americans with sleep-related breathing disorders, like sleep apnea, by keeping their airways open while they sleep. But one manufacturer, Philips Respironics, is coming under fire for a critical change it made to millions of…

Continue watching

Oct 28

What an FDA advisory panel’s finding that oral phenylephrine is ineffective means for cold and flu meds

By Lucas A. Berenbrok, Colleen Culley, Karen Steinmetz Pater, The Conversation

The ramp-up to cold and flu season is a bad time for consumers to learn that some of their most trusted go-to products don’t actually work.

Continue reading

Sep 29

FDA plans to regulate thousands of lab tests that have long skirted oversight

By Matthew Perrone, Associated Press

The Food and Drug Administration says it plans to begin regulating laboratory-based medical tests. It's a multibillion-dollar industry that regulators say poses a growing risk to patients.

Continue reading

Jump to the First Page Previous Page
1 3 4 5 6 7 8 9 35
Next Page Jump to the Last Page

Support Provided By: Learn more

web ad

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Friday, Nov 14
  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You
  • Friends of the News Hour
PBS News

© 1996 - 2025 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You